المؤلفون: Saleh K; Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, 94800, France., Kordahi M; Department of Pathology, National Institute of Pathology, Baabda, 1003, Lebanon., Felefly T; Department of Radiation Oncology, Hotel-Dieu de France University Hospital, School of Medicine, Saint-Joseph University, Beirut, 1100, Lebanon., Kourie HR; Department of Hematology-Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, 1100, Lebanon., Khalife N; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, 94800, France.

المصدر: Pharmacogenomics [Pharmacogenomics] 2021 Jul; Vol. 22 (10), pp. 587-590. Date of Electronic Publication: 2021 Jun 21.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8042 (Electronic) Linking ISSN: 14622416 NLM ISO Abbreviation: Pharmacogenomics Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , Drug Delivery Systems/*methods , Immune Checkpoint Inhibitors/*administration & dosage , Neoplasms/*drug therapy , Proto-Oncogene Proteins p21(ras)/*antagonists & inhibitors, Acetonitriles/administration & dosage ; Drug Delivery Systems/trends ; Drug Resistance, Neoplasm/drug effects ; Drug Resistance, Neoplasm/physiology ; Humans ; Neoplasms/genetics ; Neoplasms/metabolism ; Piperazines/administration & dosage ; Proto-Oncogene Proteins p21(ras)/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism ; Pyridines/administration & dosage ; Pyrimidines/administration & dosage

المؤلفون: Saleh K; Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France., Felefly T; Department of Radiation Oncology, Hotel-Dieu de France University Hospital, School of Medicine, Saint-Joseph University, Beirut, Lebanon., Khalife N; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Kourie HR; Department of Hematology-Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

المصدر: Pharmacogenomics [Pharmacogenomics] 2021 Apr; Vol. 22 (5), pp. 247-250. Date of Electronic Publication: 2021 Mar 23.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8042 (Electronic) Linking ISSN: 14622416 NLM ISO Abbreviation: Pharmacogenomics Subsets: MEDLINE

مواضيع طبية MeSH: Molecular Targeted Therapy*, Neoplasms/*drug therapy , Oncogene Proteins, Fusion/*genetics, Humans ; Mutation/genetics ; Neoplasms/genetics ; Neoplasms/pathology ; Oncogene Proteins, Fusion/antagonists & inhibitors ; Proto-Oncogene Proteins c-met/antagonists & inhibitors ; Proto-Oncogene Proteins c-met/genetics ; Proto-Oncogene Proteins c-ret/antagonists & inhibitors ; Proto-Oncogene Proteins c-ret/genetics ; Pyrazoles/therapeutic use ; Pyridines/therapeutic use ; Pyrimidines/therapeutic use ; Receptor, trkA/antagonists & inhibitors ; Receptor, trkA/genetics